cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
G1 Therapeutics Inc
1 own
1 watching
Current Price
$0
$0.19
(2.33%)
logo-gthx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
350.04M
52-Week High
52-Week High
17.49
52-Week Low
52-Week Low
3.84
Average Volume
Average Volume
0.49M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
21.333
iconMarket Capitalization350.04M
icon52-Week High17.49
icon52-Week Low3.84
iconAverage Volume0.49M
iconDividend Yield--
iconP/E Ratio21.333
What does the G1 Therapeutics Inc do?
N/A
Read More
How much money does G1 Therapeutics Inc make?
News & Events about G1 Therapeutics Inc.
Globe Newswire
22days ago
RESEARCH TRIANGLE PARK, N.C., Jan. 11, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that on January 19th, 2023, at 11:30 AM EST, G1s Chief Executive Officer Jack Bailey will provide a corporate presentation during the virtual ...
Globe Newswire
2 months ago
RESEARCH TRIANGLE PARK, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for 14,400 shares of G1s common stock and 9,400 restricted stock units (RSUs) to five hired ...
PR Newswire
2 months ago
Big Developments Set to be Unveiled at This Year's San Antonio Breast Cancer Symposium (SABCS) Big Developments Set to be Unveiled at This Year's San Antonio Breast Cancer Symposium (SABCS) PR Newswire VANCOUVER, British Colombia, Nov. 30, 2022 FN Media Group Presents USA News Group News Commentary...
Zolmax
2 months ago
G1 Therapeutics (NASDAQ:GTHX Get Rating) had its target price cut by investment analysts at HC Wainwright from $57.00 to $34.00 in a research note issued to investors on Wednesday, The Fly reports. HC Wainwrights price objective points to a potential upside of 455.56% from the stocks previous close...
Ticker Report
2 months ago
G1 Therapeutics (NASDAQ:GTHX Get Rating) had its price objective cut by HC Wainwright from $57.00 to $34.00 in a research note issued on Wednesday, The Fly reports. HC Wainwrights price target points to a potential upside of 455.56% from the stocks previous close. GTHX has been...
Frequently Asked Questions
Frequently Asked Questions
What is G1 Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy G1 Therapeutics Inc shares?
plus_minus_icon
How can I buy G1 Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of G1 Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in G1 Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of G1 Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of G1 Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of G1 Therapeutics Inc?
plus_minus_icon
What percentage is G1 Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is G1 Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.19
(2.33%)
logo-gthx
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
SUTRO BIOPHARMA INC
SUTRO BIOPHARMA INC
$7.36
$0.03 (0.41 %)
KINNATE BIOPHARMA INC
KINNATE BIOPHARMA INC
$8.01
$0.11 (1.39 %)
GENERATION BIO CO
GENERATION BIO CO
$6.32
$0.15 (2.43 %)
CABALETTA BIO INC
CABALETTA BIO INC
$12.06
$0.14 (1.17 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
SUTRO BIOPHARMA INC
SUTRO BIOPHARMA INC
$7.36
$0.03 (0.41 %)
KINNATE BIOPHARMA INC
KINNATE BIOPHARMA INC
$8.01
$0.11 (1.39 %)
GENERATION BIO CO
GENERATION BIO CO
$6.32
$0.15 (2.43 %)
CABALETTA BIO INC
CABALETTA BIO INC
$12.06
$0.14 (1.17 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00